Showing 1971-1980 of 2150 results for "".
- Imprimis Pharmaceuticals Changes Name to Harrow Healthhttps://modernod.com/news/imprimis-pharmaceuticals-changes-name-to-harrow-health/2476233/Imprimis Pharmaceuticals announced it has formally changed its name to Harrow Health and began trading as “HROW” on the NASDAQ Capital Markets on January 2, 2019. “Our new name reflects our business model of c
- EyePoint Pharmaceuticals Added to NASDAQhttps://modernod.com/news/eyepoint-pharmaceuticals-added-to-nasdaq/2479607/EyePoint Pharmaceuticals announced that it has been selected for addition to the NASDAQ Biotechnology Index (NASDAQ: NBI). EyePoint’s addition to the NBI will become effective prior to market open on Monday, December 24, 2018. The NASDAQ Biotechnology Index is designed to track the perform
- Ophthalmic Investment Funds Led by Retinal Gene Therapy Developershttps://modernod.com/news/ophthalmic-investment-funds-led-by-retinal-gene-therapy-developers/2476147/Ophthalmology remains one of the most active areas of medical technology investment, attracting monies from venture capitalists, public markets, large ophthalmic companies, and private equity. Market Scope just published its 2017/2018 Ophthalmic Deals Book, analyzing recent ophthalmic fund
- Sangamo Announces Completion of TxCell Acquisitionhttps://modernod.com/news/sangamo-announces-completion-of-txcell-acquisition/2476169/Sangamo Therapeutics announced the completion of the acquisition of TxCell, which is now a subsidiary of Sangamo and has been delisted from the French stock market. “The acquisition of
- EyeCare Partners Acquires Holcomb Laser Centerhttps://modernod.com/news/eyecare-partners-acquires-holcomb-laser-center/2479632/EyeCare Partners (ECP) furthered its expansion into the Alabama ophthalmology market with the acquisition of Dr. William Holcomb’s Cullman, Alabama-based Holcomb Laser Center, according to an announcement from EyeCare Partners, as reported in VisionMonday. Terms of the deal were not disclo
- FDA Revamping Clearance Procedures for Medical Deviceshttps://modernod.com/news/fda-revamping-clearance-procedures-for-medical-devices/2479649/The FDA is significantly revamping the way it clears most medical devices for U.S. marketing, planning to rely far less on comparisons with much older products already on the market, according to a
- Oculis Appoints New Members of Senior Management Teamhttps://modernod.com/news/oculis-appoints-new-members-of-senior-management-team/2479655/Oculis announced the appointments of Fabio Baschiera, PharmD, MPh, PhD, as Vice President of Clinical Development, and Louie-Anne Gauthier, M.Sc., as Vice President of Strategic Marketing, Business Development and Licensing. “We are delighted to welcome Fabio and Louie-Anne to the Oculis m
- Millennial Demographics Drive Refractive Surgery Opportunity in UShttps://modernod.com/news/millennial-demographics-drive-refractive-surgery-opportunity-in-us/2479686/Wealth, health, and education are key factors in determining the opportunity for laser vision correction (LVC) procedures in the US, according to new Market Scope data. Refractive procedures are strongly driven by the country’s millennial population, and the high opportunity population is
- Webinar Today: Create a Winning Search Strategy for LASIK Practiceshttps://modernod.com/news/webinar-today-create-a-winning-search-strategy-for-lasik-practices/2479691/Workshop Digital, a digital marketing company in Virginia, and Google have partnered to host a live webinar at 4
- Prevent Blindness Elects Three New Members to National Board of Directorshttps://modernod.com/news/prevent-blindness-elects-three-new-members-to-national-board-of-directors-2/2479700/Prevent Blindness has announced that Paul Delatore, Global Head, Market Access at Alcon; Jim McGrann, Chairman & CEO of Healthy Eyes Advantage; and Rajeev S. Ramchandran, MD, Associate Professor of Ophthalmology in the University of Rochester Medical School’s Department of Ophthalmology, have